Platelet Rich Plasma Study in Lower Extremity Bypass Surgery - Full Text View

Platelet Rich Plasma Study in Lower Extremity Bypass Surgery (PRP)

This study is ongoing, but not recruiting participants.

Sponsors and Collaborators:	Lawson Health Research Institute Biomet, Inc.
Information provided by:	Lawson Health Research Institute
ClinicalTrials.gov Identifier:	NCT00517452

Purpose

The use of platelet rich plasma will decrease wound infection postop.

Condition	Phase
Atherosclerosis	Phase II Phase III

U.S. FDA Resources

Study Type:	Observational
Study Design:	Natural History, Longitudinal, Defined Population, Prospective Study

Official Title:	Phase 2-3 Observational Wound Care Study Comparing Application of Platelet Rich Plasma With Standard of Care Wound Closure in Vascular Patients Requiring a Groin Incision.

Further study details as provided by Lawson Health Research Institute:

Enrollment:	80
Study Start Date:	May 2007
Estimated Study Completion Date:	August 2007

Eligibility

Criteria

Inclusion Criteria:

Vascular surgical patients scheduled for elective lower extremity bypass surgery,aortoiliac revascularizations and endovascular AAA repair requiring a groin incision Exclusion Criteria:Patients requiring emergent procedures, unable to give informed consent

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00517452

Sponsors and Collaborators

Lawson Health Research Institute

Biomet, Inc.

Investigators


Principal Investigator:	Kirk D Lawlor	London Health Sciences Centre, University of Western Ontario

More Information

Study ID Numbers:	R-07-098
First Received:	August 16, 2007
Last Updated:	August 16, 2007
ClinicalTrials.gov Identifier:	NCT00517452
Health Authority:	Canada: Health Canada

Study placed in the following topic categories:

Arterial Occlusive Diseases

Atherosclerosis

Vascular Diseases

Arteriosclerosis

Additional relevant MeSH terms:

Cardiovascular Diseases

ClinicalTrials.gov processed this record on August 29, 2008